What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.56%
Annual Rate
CNY 0.10Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jun 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.80BCNY
267.95M · vs all stocks (USD)
Updated Sep 20, 2026
Revenue (TTM)
725.93MCNY
108.32M · vs all stocks (USD)
Updated Sep 20, 2026
Profit Margin
-2.15%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Beta
-0.0690x
vs all stocks
Updated Sep 20, 2026
52-Week Change
-41.65%
vs all stocks
Updated Sep 20, 2026
Forward Annual Dividend Yield
0.56%
vs all stocks
Updated Sep 20, 2026
Market Capitalization
1.80BCNY
267.95M · vs all stocks (USD)
Updated Sep 20, 2026
Enterprise Value
1.90BCNY
284.13M · vs all stocks (USD)
Updated Sep 20, 2026
Price to Sales (TTM)
2.47x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Price to Book (MRQ)
2.32x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to Revenue
2.62x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to EBITDA
59.96x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 20.29×.Updated Sep 20, 2026
Gross Margin
28.93%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Profit Margin
-2.15%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Margin
-2.53%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Assets (TTM)
0.43%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Equity (TTM)
-2.00%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Revenue (TTM)
725.93MCNY
108.32M · vs all stocks (USD)
Updated Sep 20, 2026
Revenue per Share (TTM)
7.42CNYUpdated Sep 20, 2026
Quarterly Revenue Growth
9.30%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Gross Profit (TTM)
221.02MCNY
32.98M · vs all stocks (USD)
Updated Sep 20, 2026
EBITDA (TTM)
93.83MCNY
14.00M · vs all stocks (USD)
Updated Sep 20, 2026
Net Income (TTM)
-15.63MCNY
-2.33M · vs all stocks (USD)
Updated Sep 20, 2026
Quarterly Earnings Growth (YoY)
10.56%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Cash Flow (TTM)
-127.87MCNY
-19.08M · vs all stocks (USD)
Updated Sep 20, 2026
Levered Free Cash Flow (TTM)
-143.30MCNY
-21.38M · vs all stocks (USD)
Updated Sep 20, 2026
Forward Annual Dividend Rate
0.1000CNYUpdated Sep 20, 2026
Forward Annual Dividend Yield
0.56%
vs all stocks
Updated Sep 20, 2026
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 20, 2026
Trailing Annual Dividend Yield
0.56%
vs all stocks
Updated Sep 20, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -62.5%.Updated Sep 20, 2026
Minority Interest (Equity)
982.78KCNYFY2025 · Dec 31, 2025
Revenue
697.83MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
443.78MCNYFY2025 · Dec 31, 2025
Gross Profit
254.05MCNYFY2025 · Dec 31, 2025
Operating Income
62.94MCNY
9.39M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
30.78MCNYFY2025 · Dec 31, 2025
Net Income
30.78MCNYFY2025 · Dec 31, 2025
EBIT
33.00MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
93.83MCNYFY2025 · Dec 31, 2025
Research & Development
133.49MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
22.54MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
5.20MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
235.04KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
2.21MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.3000CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.3000CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
100.76MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
100.76MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
30.78MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-555.51KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-181.37MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-205.43MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
24.04MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
30.78MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
4.16MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-98.52MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-117.79MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-24.06MCNYFY2025 · Dec 31, 2025
Sale of Investments
4.36MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-28.59MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-48.29MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
235.30MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-233.77MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-4.67MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-2.05MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-5.20MCNYFY2025 · Dec 31, 2025
Shares Outstanding
99.81MSharesUpdated Sep 20, 2026
Float Shares
44.68MSharesUpdated Sep 20, 2026
% Held by Insiders
57.25%
vs all stocks
Updated Sep 20, 2026
% Held by Institutions
3.27%
vs all stocks
Updated Sep 20, 2026
Total Cash (MRQ)
89.11MCNY
13.30M · vs all stocks (USD)
Updated Sep 20, 2026
Total Cash per Share (MRQ)
0.8930CNYUpdated Sep 20, 2026
Total Debt (MRQ)
196.40MCNY
29.31M · vs all stocks (USD)
Updated Sep 20, 2026
Total Debt to Equity (MRQ)
0.2658x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Current Ratio (MRQ)
2.00x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Book Value per Share (MRQ)
7.75CNYUpdated Sep 20, 2026
Total Assets
1.19BCNY
178.10M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
880.18MCNYFY2025 · Dec 31, 2025
Total Liabilities
436.04MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
313.33MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
9.35MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
426.69MCNYFY2025 · Dec 31, 2025
Cash
23.75MCNYFY2025 · Dec 31, 2025
Cash Equivalents
394.83KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
24.15MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
105.47MCNYFY2025 · Dec 31, 2025
Accounts Receivable
338.16MCNYFY2025 · Dec 31, 2025
Inventory
183.28MCNYFY2025 · Dec 31, 2025
Accounts Payable
134.86MCNYFY2025 · Dec 31, 2025
Short-term Debt
172.15MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
54.01MCNYFY2025 · Dec 31, 2025
Long-term Debt
4.28MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
99.81MCNYFY2025 · Dec 31, 2025
Retained Earnings
-20.28MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
757.47MCNY
113.03M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
14.85CNYUpdated Sep 20, 2026
52-Week High
31.73CNYUpdated Sep 20, 2026
52-Week Change
-41.65%
vs all stocks
Updated Sep 20, 2026
Beta
-0.0690x
vs all stocks
Updated Sep 20, 2026
50-Day MA
17.79CNYUpdated Sep 20, 2026
200-Day MA
23.38CNYUpdated Sep 20, 2026
Avg 10-Day Volume
1.10MSharesUpdated Sep 20, 2026
Avg 30-Day Volume
1.33MSharesUpdated Sep 20, 2026
Diluted EPS (TTM)
-0.1600CNYUpdated Sep 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.